Medicare Enrolled

Dr. Neel Shah, MD

Neurology · Midland, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
400 ROSALIND REDFERN GROVER PKWY STE 120, Midland, TX 79701
4322215970
In practice since 2012 (13 years)
NPI: 1861752529 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shah

Dr. Neel Shah is a neurology in Midland, TX, with 13 years in practice. Based on federal Medicare data, Dr. Shah performed 453 Medicare services across 375 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shah received a total of $1,558 from 24 pharmaceutical and/or device companies across 60 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice▲ 453 Medicare services$ $1,558 industry payments

Medicare Practice Summary

Medicare Utilization ↗
453
Medicare services
Bottom 48% in TX for neurology
375
Unique beneficiaries
$104
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~35 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity152$90$215
Office visit, established patient (30-39 min)102$93$210
Emergency department visit, high complexity40$134$552
New patient office visit, complex (60-74 min)37$162$400
Hospital follow-up visit, moderate complexity31$60$149
Hospital discharge management, 30+ min27$86$218
Office visit, established patient, complex (40-54 min)24$116$285
Initial hospital admission, high complexity24$129$407
Critical care, first 30-74 min16$154$565
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,558
Total received (2018-2024)
Avg $312/year across 5 years
Bottom 44% in TX for neurology
24
Companies
60
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,558 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$963
2022
$52
2020
$14
2019
$377
2018
$152

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$203
Inari Medical, Inc.
$170
PFIZER INC.
$137
E.R. Squibb & Sons, L.L.C.
$124
PORTOLA PHARMACEUTICALS, INC.
$117
Amgen Inc.
$110
SK Life Science, Inc.
$93
Otsuka America Pharmaceutical, Inc.
$66
Amneal Pharmaceuticals LLC
$60
Biogen, Inc.
$58
ABBVIE INC.
$56
AstraZeneca Pharmaceuticals LP
$52
Alnylam Pharmaceuticals Inc.
$47
Teva Pharmaceuticals USA, Inc.
$45
Neurocrine Biosciences, Inc.
$44
Alexion Pharmaceuticals, Inc.
$41
Vanda Pharmaceuticals Inc.
$22
Grifols USA, LLC
$18
UCB, Inc.
$18
Bausch Health US, LLC
$18
HARMONY BIOSCIENCES LLC
$16
Janssen Pharmaceuticals, Inc
$14
CARDIVA MEDICAL, INC.
$14
Genentech USA, Inc.
$14
Top 3 companies account for 32.8% of total payments
Associated products mentioned in payments ›
ANDEXXA · Activase · Aimovig · Austedo XR · BRILINTA · Briviact · CREXONT · ELIQUIS · FlowTriever · GILENYA · Gamunex-C · INGREZZA · KESIMPTA · MIGRANAL · NURTEC ODT · ONPATTRO · PONVORY · REXULTI · RYTARY · UBRELVY · ULTOMIRIS · UPLIZNA · VUMERITY · Vascular Closure Device · WAKIX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $344 per 100 Medicare services performed
Looking for a neurology in Midland?
Compare neurologys in the Midland area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
6
Per 100K population
3.5
County median income
$93,984
Nearest hospital
MIDLAND MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Shah is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Shah experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Shah performed 152 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $1,558 from 24 companies across 60 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other neurologys in Midland?
Dr. Shah's average Medicare payment per service is $104. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →